Effect of Nutritional Status on Human Paraoxonase-1 Activity in Patients with Chronic Kidney Disease

被引:10
|
作者
Sztanek, Ferenc [1 ]
Seres, Ildiko [1 ]
Harangi, Mariann [1 ]
Locsey, Lajos [2 ]
Koncsos, Peter [1 ]
Paragh, Gyoergy [1 ]
机构
[1] Univ Debrecen, Dept Med 1, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
[2] Univ Debrecen, Inst Surg, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
来源
KIDNEY & BLOOD PRESSURE RESEARCH | 2012年 / 36卷 / 01期
基金
匈牙利科学研究基金会;
关键词
Paraoxonase; Obesity; Nutritional state; C-reactive protein; Chronic kidney disease; Reverse epidemiology; Hemodialysis; CHRONIC-RENAL-FAILURE; CARDIOVASCULAR RISK-FACTORS; HEMODIALYSIS-PATIENTS; PON1; ACTIVITY; REVERSE EPIDEMIOLOGY; DIALYSIS PATIENTS; OXIDATIVE STRESS; ADIPOSE-TISSUE; INFLAMMATION; POLYMORPHISM;
D O I
10.1159/000343383
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background/Methods: The association between nutritional status, antioxidant human paraoxonase-1 (PON1) activity and low grade inflammation in hemodialized (HD) patients with chronic kidney disease (CKD) is unclear. The aim of this study was to determine PON1 paraoxonase and lactonase activities, ADMA, adiponectin and leptin concentrations, and to clarify the relationship between paraoxonase activity and a set of cardiovascular risk factors in malnourished, normal weight and obese HD patients; 114 HD patients with end-stage renal failure were enrolled. Results: Leptin levels were significantly higher and PON1 paraoxonase activities were significantly lower in obese patients compared to the other groups. Plasma adiponectin concentration was significantly lower in obese subjects compared to malnourished patients. Paraoxonase activity was negatively correlated with CRP level in HD and malnourished patients. Furthermore, we found significant inverse correlation between paraoxonase activity and BMI in the whole patient group. In multiple regression analysis, PON1 lactonase activity, CRP level and leptin concentration proved to be independent predictors of paraoxonase activity. Conclusion: Despite the previous findings of reverse epidemiology for the mortality rate of HD patients, further studies are needed to clarify the effects of nutritional state on atherosclerosis in obese and malnourished patients with end-stage renal failure. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:310 / 319
页数:10
相关论文
共 50 条
  • [1] ASSOCIATION OF PARAOXONASE ACTIVITY WITH NUTRITIONAL STATUS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Paragh, G.
    Sztanek, F.
    Harangi, M.
    Locsey, L.
    Koncsos, P.
    Hueloep, P.
    Seres, I.
    ATHEROSCLEROSIS, 2014, 235 (02) : E243 - E243
  • [2] Cardioprotective Role for Paraoxonase-1 in Chronic Kidney Disease
    Dube, Prabhatchandra
    Khalaf, Fatimah K.
    DeRiso, Armelle
    Mohammed, Chrysan J.
    Connolly, Jacob A.
    Battepati, Dhanushya
    Lad, Apurva
    Breidenbach, Joshua D.
    Kleinhenz, Andrew L.
    Khatib-Shahidi, Bella
    Patel, Mitra
    Tassavvor, Iman
    Gohara, Amira F.
    Malhotra, Deepak
    Morgan, Eric E.
    Haller, Steven T.
    Kennedy, David J.
    BIOMEDICINES, 2022, 10 (09)
  • [3] Discordance in Human Paraoxonase-1 Gene between Phenotypes and Genotypes in Chronic Kidney Disease
    Paragh, Gyorgy
    Seres, Ildiko
    Harangi, Mariann
    Pocsai, Zsuzsa
    Asztalos, Laszlo
    Locsey, Lajos
    Szeles, Gyorgy
    Kardos, Laszlo
    Varga, Eva
    Karpati, Istvan
    Adany, Roza
    NEPHRON CLINICAL PRACTICE, 2009, 113 (01): : C46 - C53
  • [4] Evaluation of Paraoxonase-1 Activity in Chronic Obstructive Pulmonary Disease
    Agilli, Mehmet
    Aydin, Fevzi Nuri
    Cayci, Tuncer
    Kurt, Yasemin Gulcan
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 12 (04) : 468 - 469
  • [5] Paraoxonase-1 Regulation of Renal Inflammation and Fibrosis in Chronic Kidney Disease
    Khalaf, Fatimah K.
    Mohammed, Chrysan J.
    Dube, Prabhatchandra
    Connolly, Jacob A.
    Lad, Apurva
    Ashraf, Usman M.
    Breidenbach, Joshua D.
    Su, Robin C.
    Kleinhenz, Andrew L.
    Malhotra, Deepak
    Gohara, Amira F.
    Haller, Steven T.
    Kennedy, David J.
    ANTIOXIDANTS, 2022, 11 (05)
  • [6] DIFFERENT PARAOXONASE-1 (PON1) ACTIVITIES IN CHRONIC KIDNEY DISEASE AND RENAL TRANSPLANT PATIENTS
    Simic-Ogrizovic, Sanja
    Kotur-Stevuljevic, Jelena
    Dopsaj, Violeta
    Bogavac-Stanojevic, Natasa
    Lezaic, Visnja
    Jelic-Ivanovic, Zorana
    TRANSPLANT INTERNATIONAL, 2009, 22 : 287 - 287
  • [7] Paraoxonase-1 status in patients with hereditary hemochromatosis
    Martinelli, Nicola
    Garcia-Heredia, Anabel
    Roca, Helena
    Aranda, Nuria
    Arija, Victoria
    Mackness, Bharti
    Mackness, Michael
    Busti, Fabiana
    Aragones, Gerard
    Pedro-Botet, Juan
    Pedica, Federica
    Cataldo, Ivana
    Marsillach, Judit
    Joven, Jorge
    Girelli, Domenico
    Camps, Jordi
    JOURNAL OF LIPID RESEARCH, 2013, 54 (05) : 1484 - 1492
  • [8] RENOPROTECTIVE ROLE OF PARAOXONASE-1 IN AN ADENINE INDUCED MODEL OF CHRONIC KIDNEY DISEASE
    Dube, Prabhatchandra
    Gorthi, Snigdha
    Kashaboina, Esha
    Kashaboina, Eshita
    Cherian, Michelle
    Guzzoni, Vinicius
    Lad, Apurva
    Timalsina, Bivek
    Faleel, Dhilhani
    French, Benjamin
    Malhotra, Deepak
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (07) : 134 - 135
  • [9] Genetic polymorphisms of paraoxonase-1 are associated with chronic kidney disease in Japanese women
    Ichikawa, Kazunobu
    Konta, Tsuneo
    Emi, Mitsuru
    Toriyama, Sayumi
    Takasaki, Satoshi
    Ikeda, Ami
    Shibata, Yoko
    Takabatake, Noriaki
    Takeishi, Yasuchika
    Kato, Takeo
    Kawata, Sumio
    Kubota, Isao
    KIDNEY INTERNATIONAL, 2009, 76 (02) : 183 - 189
  • [10] The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters
    Mirdamadi, Hossein Z.
    Sztanek, Ferenc
    Derdak, Zoltan
    Seres, Ildiko
    Harangi, Mariann
    Paragh, Gyoergy
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (03) : 366 - 374